These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2005-001925-27 Phase I/II clinical trial of T cell suicide gene therapy following haploidentical stem cell transplantation not-yet-due
Completed, but no date Terminated 2005-002148-25 A double blind randomised control trial of perioperative glutamine administration: a potential therapy for preventing post-operative immune hypo-responsiveness. bad-data
Ongoing 2005-004122-70 Immunogenicity of conjugate pneumococcal vaccine (Prevenar) in patients with ataxia -telangiectasia (AT) including a randomised study of one versus two doses of vaccine. not-yet-due
Other 2006-000675-15 Open label Randomised Controlled Trial comparing povidone-iodine 10% with alcohol and 0.5% chlorhexidine with alcohol for prevention of early infection associated with insertion of central venous acce... not-yet-due
Exempt 2010-018447-34 Investigation of dendritic cell vaccine immunotherapy in paediatric high grade glioma not-yet-due
Exempt 2010-020797-41 NEMO1: An open label exploratory dose finding and pharmacokinetic clinical trial of bumetanide for the treatment of NEonatal seizures using Medication Off-patent. 2012-11-13 not-yet-due
Exempt 2010-024253-36 Phase I/II, historical controlled, open-label, non-randomised, single-centre trial to assess the safety and efficacy of EF1αS-ADA lentiviral vector mediated gene modification of autologus CD34+ cells ... not-yet-due
Not reported 2012-003790-25 Comparison of measured versus predicted blood propofol concentrations in children undergoing spinal surgery 2013-07-03 due-trials
Ongoing 2013-003257-20 Evaluation of Treosulfan pharmacokinetics (PK) in children undergoing allogeneic haematopoietic stem cell transplantation (HSCT) not-yet-due
Ongoing, reported early 2014-002996-27 Optimising effectiveness and minimising toxicity of intravenous salbutamol in children with acute asthma not-yet-due
Ongoing 2014-004272-29 Phase II clinical trial to evaluate safety and efficacy of mobilisation and collection of CD34+ cells after treatment with plerixafor and filgrastim in patients with Fanconi anaemia for subsequent tra... not-yet-due